Page last updated: 2024-08-24

triazoles and Mastocytosis, Systemic

triazoles has been researched along with Mastocytosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Craig, AW; Everingham, S; Kapur, R; Sharma, N; Zeng, LF; Zhang, ZY	1

Other Studies

1 other study(ies) available for triazoles and Mastocytosis, Systemic

Article	Year
Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice. Oncotarget, 2014, Aug-15, Volume: 5, Issue:15 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Dasatinib; Disease Progression; Drug Synergism; Humans; Indoles; Mastocytosis, Systemic; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-kit; Signal Transduction; Triazoles	2014

Article

Year

Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.

Oncotarget, 2014, Aug-15, Volume: 5, Issue:15

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Dasatinib; Disease Progression; Drug Synergism; Humans; Indoles; Mastocytosis, Systemic; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-kit; Signal Transduction; Triazoles

2014